Trial Profile
Clinical Trials Insight: 700037611
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Oct 2008
Price :
$35
*
At a glance
- Drugs SYI 2074 (Primary)
- Indications Coronary disorders; Myocardial reperfusion injury
- Focus Therapeutic Use
- Sponsors Synvista Therapeutics
- 01 Oct 2008 New trial record.